|
| Exchange Received Time 12/06/2018 17:17:29 Exchange Disseminated Time 12/06/2018 17:17:35 Time Taken 00:00:06 | Dear Sirs,
Sub: Sun Pharma receives EIR for Halol facility
This is with reference to our letter dated June 08, 2018 to the stock exchanges providing our clarification on the US FDA inspection at the Company's Halol facility wherein interalia we had indicated that once we receive the Establishment Inspection Report (EIR), we would immediately inform the exchanges.
We are now pleased to inform you that we have received EIR in respect of which we are issuing the enclosed Press Release after sending this letter to you.
This is for your information and necessary dissemination.
Thanking you,
|
|
|